Skip to main content

READYSTATE ASSET MANAGEMENT LP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1900923 CHICAGO, IL

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$330,476
+$330,476 QoQ
Shares Held
530
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#915
of 1,322 holders
Holding Since
Mar 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Jun 30, 2026
CallValue
$623,540
CallShares
1,000
PutValue
$623,540
PutShares
1,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

READYSTATE ASSET MANAGEMENT LP holds $170,733,904 across 15 Biotechnology names. REGN ranks #14 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in REGN

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $623,540 1,000
2026-06-30 $330,476 530
2026-06-30 $623,540 1,000
2026-03-31 $772,640 1,000
2026-03-31 $772,640 1,000
2024-12-31 $213,699 300
2024-12-31 $1,709,592 2,400
2024-09-30 $9,250,912 8,800
2024-09-30 $5,762,897 5,482
2024-09-30 $13,876,368 13,200
2024-06-30 $630,618 600
2024-06-30 $420,412 400
2024-03-31 $10,491,141 10,900
2024-03-31 $10,394,892 10,800
2023-12-31 $351,316 400
2023-12-31 $351,316 400
2023-09-30 $246,888 300
2023-09-30 $246,888 300
2023-06-30 $215,562 300
2023-06-30 $215,562 300
2023-03-31 $328,668 400
2023-03-31 $328,668 400